GK
MEDP icon

Graney & King’s Medpace MEDP Stock Holding History

Graney & King’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.6K Hold
20
– – 0.01% 240
2025
Q4 		$11.2K Hold
20
– – 0.01% 230
2025
Q3 		$10.3K Buy
+20
New +$8.73K 0.01% 230

Other funds holding MEDP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Graney & King's MEDP Position: Q1 2026 in Review

Graney & King held its Medpace (MEDP) position steady in Q1 2026 at 20 shares worth $9.6K. The position accounts for 0.01% of the portfolio, ranked #240.

Graney & King first reported a position in MEDP in Q3 2025 and has held it in 3 quarters since. The position peaked at $11.2K in Q4 2025. 729 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

  • Graney & King held 20 shares of Medpace worth $9.6K as of Q1 2026.
  • Graney & King left its Medpace share count unchanged in Q1 2026.
  • Medpace made up 0.01% of Graney & King's portfolio in Q1 2026, its #240 holding.
  • Graney & King first reported a position in Medpace in Q3 2025 and has held it in 3 quarters since.
  • Graney & King's Medpace position peaked at $11.2K in Q4 2025.
  • 729 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on Graney & King's 13F filing for Q1 2026, filed 18 May 2026.